Unknown

Dataset Information

0

Disruption of CD8+ Treg activity results in expansion of T follicular helper cells and enhanced antitumor immunity.


ABSTRACT: Tumor growth is associated with the inhibition of host antitumor immune responses that can impose serious obstacles to cancer immunotherapy. To define the potential contribution of Qa-1-restricted CD8 regulatory T cells (Treg) to the development of tumor immunity, we studied B6.Qa-1 D227K mice that harbor a point mutation in the MHC class Ib molecule Qa-1 that impairs CD8 Treg suppressive activity. Here, we report that the growth of B16 melanoma is substantially delayed in these Qa-1-mutant mice after therapeutic immunization with B16 melanoma cells engineered to express granulocyte macrophage colony-stimulating factor compared with Qa-1 B6-WT controls. Reduced tumor growth is associated with enhanced expansion of follicular T helper cells, germinal center B cells, and high titers of antitumor autoantibodies, which provoke robust antitumor immune responses in concert with tumor-specific cytolytic T cells. Analysis of tumor-infiltrating T cells revealed that the Qa-1 DK mutation was associated with an increase in the ratio of CD8(+) T effectors compared with CD8 Tregs. These data suggest that the CD8(+) T effector-Treg ratio may provide a useful prognostic index for cancer development and raise the possibility that depletion or inactivation of CD8 Tregs represents a potentially effective strategy to enhance antitumor immunity.

SUBMITTER: Alvarez Arias DA 

PROVIDER: S-EPMC4217219 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Disruption of CD8+ Treg activity results in expansion of T follicular helper cells and enhanced antitumor immunity.

Alvarez Arias Diana A DA   Kim Hye-Jung HJ   Zhou Penghui P   Holderried Tobias A W TA   Wang Xuan X   Dranoff Glenn G   Cantor Harvey H  

Cancer immunology research 20131231 3


Tumor growth is associated with the inhibition of host antitumor immune responses that can impose serious obstacles to cancer immunotherapy. To define the potential contribution of Qa-1-restricted CD8 regulatory T cells (Treg) to the development of tumor immunity, we studied B6.Qa-1 D227K mice that harbor a point mutation in the MHC class Ib molecule Qa-1 that impairs CD8 Treg suppressive activity. Here, we report that the growth of B16 melanoma is substantially delayed in these Qa-1-mutant mice  ...[more]

Similar Datasets

| S-EPMC8190041 | biostudies-literature
| S-EPMC6385600 | biostudies-literature
| S-EPMC9452889 | biostudies-literature
| S-EPMC8484368 | biostudies-literature
| S-EPMC5671557 | biostudies-literature
| S-EPMC10846313 | biostudies-literature
| S-EPMC6481611 | biostudies-literature
| S-EPMC10869348 | biostudies-literature
| S-EPMC3428098 | biostudies-literature
| S-EPMC3116644 | biostudies-literature